Market Overview:
The global lomustine (CAS 13010-47-4) market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of cancer, increasing demand for lomustine (CAS 13010-47-4) in emerging markets, and growing focus on research and development activities. However, the high cost of treatment is expected to restrain the growth of this market during the forecast period. Based on type, the global lomustine (CAS 13010-47-4) market can be segmented into 10mg/tablet, 40mg/tablet, and 100mg/tablet. Based on application, it can be divided into hospital pharmacies, retail pharmacies, and online pharmacies.
 Industry Outlook.svg)
Product Definition:
Lomustine (CAS 13010-47-4) is an alkylating agent that is used to treat various forms of cancer. It works by interfering with the DNA replication process, which ultimately leads to the death of tumor cells. Lomustine is important for the treatment of a variety of cancers, including brain tumors, Hodgkin's lymphoma, and lung cancer.
10mg/Tablet:
10mg/Tablet, it’s also known as dépigmentation tablets or Lomustine. It’s a prescription medicine used for the treatment of melanoma and other skin cancers. The drug was approved by the FDA in 1970 and is still one of the most commonly prescribed medicines for cancer treatment across the globe.
40mg/Tablet:
40mg/Tablet is a form of Lomustine (CAS 13010-47-4) and it's main function is to control the seizures. It works by decreasing the activity in certain nerve cells in the brain that are responsible for causing seizures.
It’s used along with other medicines to treat partial onset of status epilepticus.
Application Insights:
The global lomustine market is segmented by application into hospital pharmacies, retail pharmacies, and online pharmacies. The online pharmacy segment is anticipated to witness the fastest growth over the forecast period owing to increasing demand for cost-effective treatment options across the globe.
Hospital Pharmacies were estimated as the largest application segment in 2017 and are expected to maintain their dominance throughout the forecast years due largely to high usage rates of lomustine coupled with rising awareness about this drug among healthcare professionals. In addition, favorable reimbursement policies coupled with low prices of generic drugs are expected drive growth in this segment over next few years.
Regional Analysis:
North America dominated the global market in 2017. The growth is attributed to the increasing number of cancer patients opting for lomustine treatment and growing awareness about available treatments. In addition, high healthcare expenditure and availability of insurance coverage are also driving factors for this region. Moreover, rising government initiatives to increase access to novel drugs is expected to fuel the demand further over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to unmet clinical needs coupled with rapidly improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in public & private funding for R&D activities will boost industry expansion over next eight years (2018-28). For instance, Novartis invested around USD X million between 2011-2016 on research programs relatedto CLL & CFS at its facility in Gurgaon (India).
Growth Factors:
- Increasing incidence of cancer
- Growing demand for chemotherapy drugs
- Rising awareness about cancer and its treatment options
- Technological advancements in the field of oncology
- Availability of generic versions of branded drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Lomustine (CAS 13010-47-4) Market Research Report
By Type
10mg/Tablet, 40mg/Tablet, 100mg/Tablet
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Companies
Medicon Pharma, Nanjing Pharma, Bristol-Myers Squibb, NextSource Pharma, Zhongfu Pharma, Miracalus Pharma, ACTIZA, Ther Dose
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Lomustine (CAS 13010-47-4) Market Report Segments:
The global Lomustine (CAS 13010-47-4) market is segmented on the basis of:
Types
10mg/Tablet, 40mg/Tablet, 100mg/Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medicon Pharma
- Nanjing Pharma
- Bristol-Myers Squibb
- NextSource Pharma
- Zhongfu Pharma
- Miracalus Pharma
- ACTIZA
- Ther Dose
 Market Overview.svg)
Highlights of The Lomustine (CAS 13010-47-4) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10mg/Tablet
- 40mg/Tablet
- 100mg/Tablet
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lomustine (CAS 13010-47-4) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lomustine is a chemotherapy agent that is used to treat cancer. It works by killing cancer cells.
Some of the major players in the lomustine (cas 13010-47-4) market are Medicon Pharma, Nanjing Pharma, Bristol-Myers Squibb, NextSource Pharma, Zhongfu Pharma, Miracalus Pharma, ACTIZA, Ther Dose.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lomustine (CAS 13010-47-4) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Lomustine (CAS 13010-47-4) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Lomustine (CAS 13010-47-4) Market - Supply Chain
4.5. Global Lomustine (CAS 13010-47-4) Market Forecast
4.5.1. Lomustine (CAS 13010-47-4) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Lomustine (CAS 13010-47-4) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Lomustine (CAS 13010-47-4) Market Absolute $ Opportunity
5. Global Lomustine (CAS 13010-47-4) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Type
5.3.1. 10mg/Tablet
5.3.2. 40mg/Tablet
5.3.3. 100mg/Tablet
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Lomustine (CAS 13010-47-4) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Application
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Lomustine (CAS 13010-47-4) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Lomustine (CAS 13010-47-4) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Lomustine (CAS 13010-47-4) Demand Share Forecast, 2019-2026
9. North America Lomustine (CAS 13010-47-4) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Application
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Pharmacies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Type
9.7.1. 10mg/Tablet
9.7.2. 40mg/Tablet
9.7.3. 100mg/Tablet
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Lomustine (CAS 13010-47-4) Demand Share Forecast, 2019-2026
10. Latin America Lomustine (CAS 13010-47-4) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Application
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Type
10.7.1. 10mg/Tablet
10.7.2. 40mg/Tablet
10.7.3. 100mg/Tablet
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Lomustine (CAS 13010-47-4) Demand Share Forecast, 2019-2026
11. Europe Lomustine (CAS 13010-47-4) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Application
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Type
11.7.1. 10mg/Tablet
11.7.2. 40mg/Tablet
11.7.3. 100mg/Tablet
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Lomustine (CAS 13010-47-4) Demand Share, 2019-2026
12. Asia Pacific Lomustine (CAS 13010-47-4) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Application
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Type
12.7.1. 10mg/Tablet
12.7.2. 40mg/Tablet
12.7.3. 100mg/Tablet
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Lomustine (CAS 13010-47-4) Demand Share, 2019-2026
13. Middle East & Africa Lomustine (CAS 13010-47-4) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Application
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Lomustine (CAS 13010-47-4) Market Size and Volume Forecast by Type
13.7.1. 10mg/Tablet
13.7.2. 40mg/Tablet
13.7.3. 100mg/Tablet
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Lomustine (CAS 13010-47-4) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Lomustine (CAS 13010-47-4) Market: Market Share Analysis
14.2. Lomustine (CAS 13010-47-4) Distributors and Customers
14.3. Lomustine (CAS 13010-47-4) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medicon Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Nanjing Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bristol-Myers Squibb
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. NextSource Pharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Zhongfu Pharma
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Miracalus Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ACTIZA
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Ther Dose
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
